Fragile X syndrome is associated with a CGG repeat expansion in the 5′-untranslated region of the FMR-1 gene. Within the FMR-1 promoter a CpG island is frequently methylated in fragile X patients. To identify the effect of methylation on FMR-1 expression, we transfected methylated and unmethylated constructs containing the FMR-1 promoter in front of the CAT gene (pFXCAT) into COS-1 cells. No difference between methylated and unmethylated DNA was observed initially, whereas reduced CAT mRNA levels were observed 48 h post-transfection of the methylated construct and increased CAT activity from unmethylated DNA was observed at 72 h. To determine the effect of a CGG repeat expansion on gene expression, we inserted >200 CGG repeats between the SV40 promoter and the CAT gene (pSV2CAT). A 3-fold reduction in CAT activity was observed 24-48 h post-transfection. To study the correlation between CGG repeat expansion and FMR-1 transcription, we inserted 200 CGG trinucleotide repeats into the pFXCAT construct. Only a slight difference in mRNA levels was found between cells transfected with pFX(CGG) 200 CAT or pFXCAT, but a complete lack of CAT activity was observed with introduction of the repeat. We conclude that a moderate size repeat markedly reduces translation. We propose that the presence of a repeat expansion per se is the major factor influencing FMR-1 function in fragile X syndrome.
INTRODUCTION
Fragile X syndrome is one of the most common forms of inherited mental retardation, with a frequency of 1 in 1250 men and 1 in 2500 females (1) . The syndrome is strongly correlated with a fragile site at Xq27. 3 and results from loss of activity of the FMR-1 gene. In many cases fragile X syndrome is due to an expansion of a CGG repeat located in the 5′-untranslated region (5′-UTR) of the FMR-1 gene (2, 3) . In the normal population the CGG repeat of the FMR-1 gene is 2-60 units long. However, individuals with fragile X syndrome show a repeat containing >200 CGG repeats (4) (5) (6) (7) . Thus, fragile X syndrome is one of a group of disorders associated with trinucleotide repeat expansion (2) .
The FMR-1 gene codes for the FMR-1 protein (FMRP), with possible functions in RNA metabolism or in RNA-containing cellular structures (8, 9) . RNA binding studies have shown that FMRP is able to bind to its own messenger RNA as well as 4% of human fetal brain mRNA (10) . Furthermore, it was recently demonstrated that FMRP interacts with the novel homologues FXR1 and FXR2. The proteins can associate with each other or form homomers (11) . Eberhart et al. (12) showed that FMRP is a ribonucleoprotein containing both nuclear localization and nuclear export signals. The FMR-1 gene is expressed at high levels in most, if not all, cells during development, whereas the adult expression pattern is non-uniform, with high levels in organs affected by fragile X syndrome such as brain and testis (13) .
Methylation of CpG sequences, preferentially in the promoter regions, is part of the regulation of gene expression and cell differentiation (14, 15) . In the FMR-1 promoter region one CpG island is positioned 250 bp upstream of the CGG repeat. This CpG island is frequently found to be methylated in fragile X patients, demonstrating an inverse correlation between DNA methylation and gene expression (16) (17) (18) (19) . The role of the CGG expansions in establishing the methylation pattern in the CpG island is not known. However, some results indicate that expanded CGG or CCG repeats could display conformational changes which probably induce de novo methylation (20) . DNA methylation will in this case serve to stabilize the structure and possibly label the repeat for repair (21) .
Recent studies of a fragile X syndrome patient suggest that CGG repeat expansion may disturb translation in the absence of methylation (22) . It is thus unclear how methylation itself regulates FMR-1 gene activity and if the methylation frequently observed in fragile X patients is an epiphenomenon or if it has direct effects on FMR-1 gene function.
In this investigation we asked whether it is the CGG repeat expansion, DNA methylation of the FMR-1 promoter or a combination thereof that mediates the lowering of gene activity.
MATERIALS AND METHODS

Plasmid construction
The XbaI-BamHI fragment from plasmid pE5.1 (David L.Nelson, Baylor College of Medicine, Houston, TX), containing the 5′-end of the FMR-1 gene, was ligated to the XbaI site in the multiple cloning site of pBCAT (Promega, Madison, WI). Both open ends were blunted by DNA polymerase fill-in reaction preceding blunt end ligation. The ligated product was propagated in Escherichia coli Hb 101 as pFXCAT (Fig. 1) .
A PCR product containing 200 CGG repeats from a male fragile X patient was treated with DNA polymerase 3′ exonuclease activity and blunt end ligated in the HindIII site of pSV2CAT. For construction of pFX(CGG) 200 CAT the CGG repeat product was first cleaved with PstI and XhoI and then inserted in the pFXCAT construct. For PCR amplification of the CGG repeat expansion Dynazyme tbr DNA polymerase (Finnzymes OY, Finland) was used with upstream primer (primer 1) TGCAGAAATG GGCGT-TCTGG and downstream primer (primer 2) GCCCTAGAGC CAAGTACCTT GT. An aliquot of 0.1 µg genomic DNA was added to a solution of 10% DMSO, 0.20 mM dNTP, 10× Dynazyme buffer containing 2.5 mM MgCl 2 , 2 U Dynazyme and 6 µM of each primer. The amplification profile was as follows: 94_C for 4 min, four cycles of 94_C for 1 min, 57_C for 2 min, 72_C for 3 min and 31 cycles of 94_C for 35 s, 57_C for 40 s, 72_C for 2.30 min. The PCR product was purified after agarose gel electrophoresis using DNA Purification Kit Prep-A-Gene® (BioRad, Hercules, CA) before further treatment.
In vitro methylation
An aliquot of 10 µg plasmid DNA was incubated with HpaII methyltransferase (Fermentas, Lithuania) overnight at 37_C in a reaction mixture containing 50 mM Tris-HCl, pH 7.5, 300 mM S-adenosylmethionine (SAM), 10 mM EDTA and 5 mM dithiothreitol (DTT). The reaction was terminated by adding 200 µg/ml proteinase K for 1 h at 37_C followed by phenol extraction and chloroform/isoamyl alcohol (24:1). The DNA was precipitated with ethanol. The efficiency of methylation was controlled by digestion of methylated pFXCAT with HpaII and MspI. Prior to transfection the methylated DNA was cut with HpaII and purified by agarose gel electrophoresis.
Cell culture and transfection
COS-1 cells were grown in Dulbecco's modified Eagle's medium (DMEM; Gibco BRL, Gaithesburg, MD) supplemented with 10% fetal calf serum and 2 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. Samples of 1 × 10 6 cells were transfected with 2 µg supercoiled methylated or unmethylated pFXCAT DNA. Electroporation was used to transfect cells that were pulsed at 1050 µF, 220 V with a pulse time of ∼25 ms.
CAT assay
To control the activity of the CAT gene, the recipient cells were harvested at different time points after transfection. The cells were washed with PBS and scraped off with a rubber policeman. Total cell extracts were transferred to Eppendorf tubes filled with 150 µl 0.25 M Tris-HCl, pH 7.8, sonicated and incubated at 60_C for 10 min. After centrifugation for 10 min the supernatant was used for enzymatic reaction with [ 14 C]chloramphenicol and acetyl-CoA.
To each tube 20 µl acetyl-CoA (4 mM) and 2 µl 200 µCi [ 14 C]chloramphenicol were added. The mixture was incubated for 17 h at 37_C. After incubation chloramphenicol and its derivatives were extracted with ethyl acetate and the acetylated chloramphenicol (AC) and the non-acetylated form were separated on thin layer silica gel plates (Merck, Darmstadt, Germany). The plates were developed in chloroform/methanol (95:5) and then autoradiographed (23) . The percentage conversion of [ 14 C]chloramphenicol to the acetylated form (AC) was quantified using a Fuji Bas 1000 IP Reader (Fuji, Japan).
RT-PCR
For first strand cDNA synthesis 1 µg total RNA from transfected cells (24) dissolved in DEPC-treated water was used with a Ready To Go kit (Pharmacia Biotech, Uppsala, Sweden) containing M-MuLV reverse transcriptase and an oligo(dT) primer to generate first strand cDNA. The RNA sample was denatured and placed at 37_C for 60 min. The complete first strand reaction was heat inactivated at 90_C for 5 min. An aliquot of 5 µl first strand reaction was used for PCR amplification. Amplifications were initially carried out using the primers (CAT-1) GAGGGCATTTCA-GTCAGTTGC and (CAT-2) TGAAACTCACCCAGGGATTG, corresponding to nucleotides 4985-5007 and 5359-5378 of the CAT gene. The reaction contained 10 µl 10× Dynazyme buffer,1 µl 20 mM dNTP mix, 30 pmol upstream primer (CAT-1), 30 pmol downstream primer (CAT-2) and water to 100 µl and 2.5 U Dynazyme enzyme. The PCR amplification profile was 94_C for 4 min, four cycles of 94_C for 1 min, 57_C for 2 min, 72_C for 3 min and 31 cycles of 94_C for 35 s, 57_C for 40 s, 72_C for 2.30 min. The PCR products were monitored on a 1% agarose gel.
RESULTS
The purpose of this study was to determine the effect of in vitro methylation of the FMR-1 promoter region and insertion of a CGG repeat expansion in the 5′-UTR of FMR-1 on gene expression in cell culture. We therefore constructed a plasmid containing the FMR-1 promoter and the transcription start and exon 1 from FMR-1 in front of the CAT gene and SV40 small t antigen (pFXCAT; Fig. 1 ).
In vitro methylation
To change the methylation state of this construct, we incubated the pFXCAT construct with the methyltransferase M.HpaII so that the internal cytosine in the CCGG target sequence was methylated (the positions of the nine HpaII sites in the CpG island are indicated in Figure 1 ). C 5m CGG methylation inhibits HpaII but not MspI digestion. Both enzymes were used to control for methylation efficiency. In order to assess the effect of methylation on gene expression, COS-1 cells were transfected with the modified DNA. Prior to transfection the methylated DNA was digested with HpaII, separated by gel electrophoresis and purified to exclude contamination with unmethylated DNA. Recipient cells were harvested at various intervals after transfection. In vitro methylation of the FMR-1 promoter did not change the CAT activity of pFXCAT during the first 48 h after gene transfer (Table 1 ) and the activity was similar to that after transfection of non-methylated DNA. At 72 h after transfection a 3-fold increase in CAT activity was observed with the unmethylated contruct, whereas methylated pFXCAT remained at low levels ( Table 1 ). The level of CAT mRNA was determined by RT-PCR of RNA prepared from cells 48 h after transfection of methylated and unmethylated pFXCAT. No CAT mRNA was detected in cells transfected with methylated pFXCAT, however RNA isolated from cells transfected with unmethylated pFXCAT resulted in a 396 bp fragment after RT-PCR (Fig. 2) .
CGG repeat expansion and FMR-1 promoter activity
The CGG repeat expansion in the first exon of the FMR-1 gene is assumed to have an important role in development of the fragile X phenotype (3) (4) (5) 7, 16) . To characterize the effect of a CGG repeat expansion (≥200) on gene expression in general, we PCR amplified a DNA fragment from a male fragile X patient with an expanded repeat (Fig. 3) . PCR amplification of this ∼1000 bp sequence containing 100% GC was non-trivial and different conditions were therefore evaluated. The PCR amplification resulted in a product of 1000 bp containing ∼200 CGG repeats (Fig. 3) . The CGG 200 sequence was then blunt ended by a DNA polymerase fill-in reaction and inserted in construct pSV2CAT (Fig. 4A) . Plasmid pSV2CAT contains the early SV40 promoter controlling the CAT gene and SV40 poly(A) signal. To determine the biological activity, COS-1 cells were transfected with pSV2CAT or pSV2(CGG) 200 CAT. The CAT activity was reduced to <20% acetylation with pSV2(CGG) 200 CAT, whereas transfection with pSV2CAT resulted in 80% acetylation at 24 and 48 h post-transfection (Fig. 5) .
To examine the effect of a CGG repeat expansion on FMR-1 promoter activity, plasmid pFXCAT was modified with an insert of the expanded CGG PCR product after PstI and XhoI digestion (Fig. 4B ). This plasmid, pFX(CGG) 200 In order to determine the biological activity of pFX(CGG) 200-CAT, we transfected methylated and unmethylated plasmid DNA into COS-1 cells. The recipient cells were harvested after 24, 48 and 72 h. Both the unmethylated and the methylated construct completely lacked all CAT activity (data not shown).
To assess the effect of CGG repeat expansion on transcriptional activity, we transfected COS-1 cells with unmethylated pFX(CGG) 200 CAT and analysed mRNA levels by RT-PCR. To study the normal rate of transcription the pFXCAT plasmid was used as a control. Only a slight difference in transcriptional activity was observed at 48 h between cells transfected with pFX(CGG) 200 CAT or pFXCAT (Fig. 6 ).
DISCUSSION
Loss of FMR-1 expression is widely accepted to be the cause of fragile X syndrome. It is, however, controversial whether this loss is the result of a CGG expansion per se or commonly occurring hypermethylation of the promoter region (22) . Furthermore, the role of CpG methylation of the CpG island in the FMR-1 promoter in regulating FMR-1 expression is still not clear. Recently it was demonstrated that methylation of all CpG dinucleotides by SssI methylase blocked FMR-1 promoter activity 48 h after transfection in the absence of a repeat expansion (27) . On the other hand, a fragile X patient with a lung tumour had FMR-1-expressing tumor cells despite methylation of both the EagI and BssHII sites in the FMR-1 promoter (30). It is possible that a special CpG site has to be methylated to reduce gene activity. Such CpG sites have previously been identified (29) and may apply also to regulation of the FMR-1 gene. Novel methylation sites may in fact be produced by the expansion itself and it has been demonstrated that DNA methyltransferase can recognize and selectively methylate unusual DNA structures like trinucleotide CGG repeats in vitro (19) . Furthermore, d(CGG) n oligonucleotides form a complex structure with properties similar to tetrahelical DNA under physiological conditions and 5-methylation of cytosine stabilizes this structure (21) .
We have studied methylation of the FMR-1 promoter and the effect of a CGG repeat expansion in the 5′-UTR in vitro. The FMR-1 promoter is a relatively weak inducer of CAT activity in COS-1 cells, despite the fact that these cells have been shown to be among the best cell lines for FMR-1 expression (31). Methylation per se did not inhibit transient expression of plasmid pFXCAT-CH 3 in COS-1 cells during the first 48 h after transfection, indicating that methylation may be less related to the loss of expression seen in patients. However, we did observe reduced transcription in cells transfected with pFXCAT-CH 3 48 h after DNA transfer, indicating that methylation may down-regulate the FMR-1 gene. This was further supported by the increase in CAT activity seen using unmethylated pFXCAT in contrast to methylated DNA 72 h post-transfection. The delayed difference in expression may also be due to chromatin assembly of the trans-DNA in the nucleus. It is well known that microinjected supercoiled plasmid DNA is assembled into minichromosomes 48-72 h after gene transfer (26) . This may lead to more efficient inhibition of the methylated construct due to interaction between methyl groups and histone octamers, histone 1 or other methyl CpG binding protein. Stability of the CAT enzyme in the cell might maintain the base level of gene activity seen in the cells transfected with methylated pFXCAT even in the absence of de novo transcription.
The biological activity of pSV2(CGG) 200 CAT was reduced as early as 24 h after gene transfer and complete loss of CAT activity was observed after transfection of pFX(CGG) 200 CAT. These findings taken together support the notion that a CGG repeat expansion alone can inhibit gene expression (22) . The presence of similar transcription levels in cells expressing pFX(CGG) 200 CAT and pFXCAT implies that translation rather than transcription is influenced by the change in the number of CGG repeat units, at least in the short size range of pathological (CGG) n expansions. These results are consistent with observations made recently using fibroblast subclones from a mildly affected fragile X patient (22) .
In conclusion, we have demonstrated that a CGG expansion as well as in vitro methylation of the FMR-1 promoter regulate gene expression. The CGG repeat expansion affects translation but not transcription and acts independently of methylation. We propose that the repeat expansion per se is a primary factor determining FMR-1 gene expression, possibly modulated by methylation events. Future studies using cell lines transfected with pFX(CGG) n CAT containing various repeat unit sizes may reveal in what way the CGG repeat expansion itself can influence the pattern of methylation of flanking CpG sequences.
